NCT01898910

Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation

Name: Clinical Trial NCT01898910
Creator: Meshalkin Research Institute of Pathology of Circulation
Keywords: Atrial Fibrillation,Hypertension, PVI+renal denervation, Phase 2, procedure, clinical trial, Russian Federation

Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation. A Randomized Comparison

Meshalkin Research Institute of Pathology of Circulation·Phase 2·ClinicalTrials.gov·procedureCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Atrial Fibrillation,Hypertension
Drug/Device/Intervention: PVI+renal denervation
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Meshalkin Research Institute of Pathology of Circulation
Location: Novosibirsk, Russian Federation

Timeline & enrollment

Phase: Phase 2
Start date: Jun 01, 2012
End date: Jun 01, 2013
Enrollment: 80 participants

Primary outcome

Freedom of AF or other atrial arrhythmias

Summary

The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different strategies, PVI plus Renal Denervation (RD) versus PVI plus GP ablation, in patients with atrial fibrillation. Results were assessed after follow-up of at least 1 year with the use of an implanted monitoring device (IMD).

ICD-10 classifications

Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT01898910
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT01898910 through Pure Global AI's free database. This Phase 2 trial is sponsored by Meshalkin Research Institute of Pathology of Circulation and is currently Completed. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.